Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0281 | ||||
Gene Name | SLC32A1 | ||||
Protein Name | Vesicular inhibitory amino acid transporter | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | GABA and glycine transporter; SLC32A1; Solute carrier family 32 member 1; VGAT; VIAAT; Vesicular GABA transporter; hVIAAT | ||||
DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
Tissue Specificity | Retina. Expressed throughout the horizontalcells or more specifically at the terminals. | ||||
Function | This transporter is involved in the uptake of GABA and glycine into the synaptic vesicles. | ||||
Endogenous Substrate(s) | Amino acids; H+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Gamma-aminobutyric acid
|
Phase 1/2 | Drug Info | Inflammatory bowel disease | DD7Z | [1] |
References | |||||
1 | Wakefulness Is Governed by GABA and Histamine Cotransmission. Neuron. 2015 Jul 1;87(1):164-78. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.